Vir(VIR) - 2025 Q4 - Earnings Call Transcript

Vir Biotechnology (NasdaqGS:VIR) Q4 2025 Earnings call February 23, 2026 05:30 PM ET Company ParticipantsJason O'Byrne - EVP and Interim CFOJohann de Bono - Regius Professor of Cancer ResearchJosh Schimmer - Senior Managing DirectorKiki Patel - Head of Investor RelationsMarianne De Backer - CEO and DirectorMark Eisner - EVP and Chief Medical OfficerPatrick Trucchio - Managing Director of Equity ResearchSean McCutcheon - VP of Biotechnology Equity ResearchConference Call ParticipantsAlec Stranahan - VP and S ...